Lifecore Biomedical, Inc. De (LFCR) Enterprise Value (2010 - 2025)

Lifecore Biomedical has reported Enterprise Value for 16 years, with the latest figure at $240.6 million in Q2 2025.

• On a quarterly basis, Enterprise Value rose 47.3% year-over-year to $240.6 million in Q2 2025; TTM through May 2025 was $240.6 million, a 47.3% increase from a year earlier, with the FY2025 full-year figure at $240.6 million, up 47.3% from the prior year.
• Enterprise Value was $240.6 million for Q2 2025 at Lifecore Biomedical, up from $202.3 million in the prior quarter.
• The five-year high for Enterprise Value was $350.4 million in Q2 2021, with the low at $163.3 million in Q2 2024.
• Average Enterprise Value over 5 years is $255.8 million, with a median of $251.3 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value tumbled 48.57% in 2023, then surged 47.3% in 2025.
• Over 5 years, Enterprise Value stood at $255.0 million in 2021, then dropped by 2.88% to $247.6 million in 2022, then dropped by 7.63% to $228.7 million in 2023, then rose by 14.04% to $260.9 million in 2024, then dropped by 7.79% to $240.6 million in 2025.
• The last three Enterprise Value figures came in at $240.6 million (Q2 2025), $202.3 million (Q1 2025), and $260.9 million (Q4 2024), per Business Quant data.